Center for Inherited Disease Research (CIDR) High Throughput Sequencing and Genotyping Resource Access (X01 Clinical Trial Not Allowed)
This NIH X01 supports access to CIDR high-throughput genotyping, sequencing, and statistical genetics services for projects aimed at identifying genetic contributors to human health and disease or enhancing biorepository specimens with genotype/sequence data.
⚑ X01 resource access mechanism; funds external use of CIDR services rather than a traditional research project · Clinical Trial Not Allowed · Non-domestic entities are listed as eligible applicants · Award ceiling listed as $0
Unit fits — one characterization, each unit's own rules
| Physical Sciences & Engineering (demo) | 80 strong | technical depth: substantial; funds data infrastructure |
| IPPRA | 43 partial | outside portfolio topics; social/behavioral work is minor; funds data/survey infrastructure; biomedical core — IPPRA health lane is communication/crisis/policy (capped) |
| Tom Love Innovation Hub | 15 none | deep-tech content; no commercialization signal |
Description
The Center for Inherited Disease Research (CIDR) high-throughput genotyping, sequencing and supporting statistical genetics services are designed to aid the identification of genes or genetic modifications that contribute to human health and disease or to enhance existing collections of well-phenotyped specimens in biorepositories by the addition of genotype or next-generation sequence data. The laboratory specializes in genomic services that cannot be efficiently carried out in individual investigator laboratories. CIDR provides the most up-to-date platforms, services and statistical genetic support. This is an NIH-wide initiative that is managed by NHGRI. Information about current services offered can be accessed via: http://www.cidr.jhmi.edu.
Eligibility
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
Apply
View on Grants.gov → CONTACT: National Institutes of Health <grantsinfo@nih.gov>
Proposal brief SEE AN EXAMPLE →
A one-page internal memo: fit assessment, submission requirements, document scaffold, and next steps dated back from the deadline — tailored to your project idea if you add one.
Proposal shell · National Institutes of Health conventions SEE AN NIH EXAMPLE →
Funder-faithful document skeletons — National Institutes of Health's document set with section headings, page limits, reviewer guidance, and writing prompts; add a project idea to get [DRAFT] starter bullets. Download as .md for Word or Overleaf.
Legacy IPPRA LLM assessment (v2.0, for comparison)
10/100 · gpt-5.4-mini · 2026-07-06
This is a genomic resource access mechanism that supports biomedical genetics work, not a research project focused on the social, behavioral, policy, or communication dimensions that IPPRA leads. The only portfolio connection is distant public-health relevance through human disease, and while public universities are eligible, the opportunity is primarily a technical service resource rather than research funding.
Legacy scoring history
| 2026-07-06 | 10 | gpt-5.4-mini | This is a genomic resource access mechanism that supports biomedical genetics work, not a research project focused on the social, behavioral, policy, or communication dimensions that IPPRA leads. The only portfolio connection is distant public-health relevance through human disease, and while public universities are eligible, the opportunity is primarily a technical service resource rather than research funding. |
| 2026-07-06 | 8 | gpt-5.4-mini | This is a genomic sequencing/genotyping infrastructure opportunity for human disease research, with no meaningful social, behavioral, policy, or risk-communication component that aligns with IPPRA’s portfolio. A public university could likely participate as an eligible applicant, but the topic is primarily technical and outside IPPRA’s core strengths. |